These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15960770)

  • 21. For-profit non-conversion and regulatory firestorm at CareFirst BlueCross BlueShield.
    Robinson JC
    Health Aff (Millwood); 2004; 23(4):68-83. PubMed ID: 15318568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Not your father's Blue Cross/Blue Shield.
    Kertesz L
    Mod Healthc; 1996 Oct; 26(42):62-4, 66, 68-70. PubMed ID: 10161930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blue Cross conversions: consumer efforts to protect the public's interests.
    Silas J; Hamburger E; Bell CW; Hunter M
    Bull N Y Acad Med; 1997; 74(2):256-85. PubMed ID: 9439863
    [No Abstract]   [Full Text] [Related]  

  • 24. Blue Shield ordered to repay withheld funds.
    Gosfield AG
    Pa Med; 1984 Jul; 87(7):34-5. PubMed ID: 6548007
    [No Abstract]   [Full Text] [Related]  

  • 25. New York's Blue Cross and Blue Shield, 1934-1990: the complicated politics of nonprofit regulation.
    Marmor TR
    J Health Polit Policy Law; 1991; 16(4):761-92. PubMed ID: 1800576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New York rate control bill forces hospitals to accept limits on Blue Cross charges.
    Hospitals; 1978 Aug; 52(16):19-20. PubMed ID: 352901
    [No Abstract]   [Full Text] [Related]  

  • 27. Avoiding state intervention in not-for-profit/for-profit affiliations.
    Whitehead R; Johnson CI; Moore PM
    Healthc Financ Manage; 1997 Dec; 51(12):56-62. PubMed ID: 10174786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Singing the Blue Cross blues.
    Behar R
    Time; 1993 Jul; 142(2):48. PubMed ID: 10126999
    [No Abstract]   [Full Text] [Related]  

  • 29. Blue Cross conversions.
    McPherson B
    Health Aff (Millwood); 2005; 24(4):1180; author reply 1180-1. PubMed ID: 16012159
    [No Abstract]   [Full Text] [Related]  

  • 30. The Empire board's responsibilities.
    Millstein IM
    Bull N Y Acad Med; 1997; 74(2):292-303. PubMed ID: 9439865
    [No Abstract]   [Full Text] [Related]  

  • 31. The impact of Blue Cross conversions on health spending and the uninsured.
    Conover CJ; Hall MA; Ostermann J
    Health Aff (Millwood); 2005; 24(2):473-82. PubMed ID: 15757933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Price controls rest in (relative) peace.
    Havighurst C
    Health Syst Rev; 1996; 29(6):28-9. PubMed ID: 10167143
    [No Abstract]   [Full Text] [Related]  

  • 33. The impact of Blue Cross conversions on accessibility, affordability, and the public interest.
    Hall MA; Conover CJ
    Milbank Q; 2003; 81(4):509-42. PubMed ID: 14678478
    [No Abstract]   [Full Text] [Related]  

  • 34. Empire wins state OK.
    Benko LB
    Mod Healthc; 2000 May; 30(22):17. PubMed ID: 11067153
    [No Abstract]   [Full Text] [Related]  

  • 35. Nonprofit conversion: theory, evidence, and state policy options.
    Marsteller JA; Bovbjerg RR; Nichols LM
    Health Serv Res; 1998 Dec; 33(5 Pt 2):1495-535. PubMed ID: 9865231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blue Cross and Blue Shield Plan contracts with providers: cost containment objectives amid conflicting legislative schemes.
    Heitler G; Ader M
    J Leg Med; 1981 Sep; 2(3):265-96. PubMed ID: 6976401
    [No Abstract]   [Full Text] [Related]  

  • 37. N.Y. Blues plan seeks to stave off takeover.
    Pallarito K
    Mod Healthc; 1992 Jul; 22(30):18. PubMed ID: 10119574
    [No Abstract]   [Full Text] [Related]  

  • 38. Conversion proceeds.
    Raske KE
    Health Aff (Millwood); 2003; 22(5):259. PubMed ID: 14515901
    [No Abstract]   [Full Text] [Related]  

  • 39. Transparency has its limits. Questions arise about why the transparency-preaching Blues association is getting quiet about its members' fiscal results.
    Benko LB
    Mod Healthc; 2006 Aug; 36(31):6-7, 16, 1. PubMed ID: 16958344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comment on Kartell v. Blue Shield of Massachusetts, Inc.: an antitrust analysis of Blue Shield's reimbursement schemes.
    Wayne AB
    Am J Law Med; 1986; 11(4):465-500. PubMed ID: 3591810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.